Suchergebnisse - "Pagnini, Cristiano"

PubPharm (5)

1

Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases : A Real-Life, Multicenter, Observational Study

enthalten in: Inflammatory bowel diseases | 2023

von Tursi, A. | Mocci, G. | Allegretta, L. | +47

ErratumIn: Inflamm Bowel Dis. 2022 Oct 3;28(10):e145. - PMID 35820045

2

Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease : A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2022

von Tursi, A. | Mocci, G. | Cuomo, A. | +89

3

Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases : a real-life multicenter, observational study in Italy

enthalten in: Expert opinion on biological therapy | 2022

von Tursi, A. | Mocci, G. | Allegretta, L. | +52

4

Similar But Not Identical : Plaque Psoriasis Exacerbation in a Patient With Crohn's Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar

enthalten in: Inflammatory bowel diseases | 2020

von Pagnini, C. | Di Paolo, M. | De Angelis, G. | +5

5

Use of biosimilars in inflammatory bowel disease : a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Fiorino, G. | Caprioli, F. | Daperno, M. | +92

1
[1]